Björn Johansson

Dr. Björn Johansson


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2008 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
JLJeanette Lindholm
Jeanette Lindholm
MGMarc Guitart-Masip
Marc Guitart-Masip
HHHoma Hassankhali
Homa Hassankhali
SLSara Landgren
Sara Landgren
CNCamille Nicoleau
Camille Nicoleau
BJBjörn Johansson
Björn Johansson

8 September 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
BJBjörn Johansson
Björn Johansson
SARS-CoV-2, the virus that causes COVID-19, spreads i. a., by respiratory droplets. The use of masks in preventing spread is controversial; masks are considered useless by many, while being mandated in some locations. Here, the effect of masking the general population on a COVID-19-like epidemic is estimated by computer simulation using three separate types of software. The main questions are whether mask use by the general population can limit the spread of SARS-CoV-2 in a country and how to identify opportunities when mask use is cost-effective and safe. To address these questions, the protective effects of different types of masks, the side-effects of masks, and avenues for improvements of masks and masking are addressed. Main results: (i) Any type of mask, even simple home-made ones, may be of value, even if the protective effect of each mask (here dubbed “one mask-protection”) is low. Strict adherence to mask use does not appear to be critical but increasing one mask-protection to >50% was found to be advantageous. (ii) Masks do seem to reduce the number of new cases even if introduced at a late stage in an epidemic, but early implementation helps reduce the cumulative and total number of cases. (iii) The simulations suggest that it might be possible to eliminate a COVID-19 outbreak by widespread mask use during a limited period. There is a brief discussion of why the reported effect size of masking varies widely, and is expected to do so, because of different filtration abilities of different masks, differences in compliance and fitting, other routes of transmission, pre-existing immunity, and because a system of interconnected, disease-prone individuals has non-linear properties. A software solution to visualize infection spread is presented. The results from these simulations are encouraging, but do not necessarily represent the real-life situation, so it is suggested that clinical trials of masks are now carried out while continuously monitoring effects and side-effects. As mask use is not without risks and costs, it is suggested that governments and scientists have an important role in advising the public about the sensible use of masks.

15 June 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Lydia Giménez-LlortLydia Giménez-Llort
Lydia Giménez-Llort
BJBjörn Johansson
Björn Johansson
Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)

27 September 2022
Verified
Conference Paper
Closed access
SASaly Abdelhadi
Saly Abdelhadi
KNKlas Nordlind
Klas Nordlind
BJBjörn Johansson
Björn Johansson
MHMikael Holst
Mikael Holst
LLLouise Lönndahl
Louise Lönndahl
Atopic dermatitis (AD) is an often severely pruritic chronic inflammatory disease often worsened by psychological stress. Calcitonin gene-related | POSTER